GRAPHITE BIO INC (GRPH)

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

Pre-market stock movers are a great way to start the week as we check out all of the biggest trades happening on Monday morning!

Graphite Bio Declares Special Dividend In Connection with Proposed Merger with Lenz Therapeutics

SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates AGE, GRPH, FIXX

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

GRAPHITE BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Graphite Bio, Inc. - GRPH

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CERE, IMGN, ROVR, GRPH

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Consolidated Communications Holdings, Inc. (Nasdaq - CNSL), Cerevel Therapeutics Holdings, Inc. (Nasdaq – CERE), ImmunoGen, Inc. (Nasdaq – IMGN), Graphite Bio, Inc.

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates GRPH, ROVR, IMGN

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: EngageSmart, Inc. (NYSE – ESMT), WaveDancer, Inc. (Nasdaq – WAVD), Graphite Bio, Inc. (Nasdaq – GRPH), CapStar Financial Holdings, Inc. (Nasdaq – CSTR)

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Hawaiian Holdings, Inc. (Nasdaq – HA), ImmunoGen, Inc. (Nasdaq – IMGN), Graphite Bio, Inc. (Nasdaq – GRPH), CapStar Financial Holdings, Inc. (Nasdaq – CSTR)

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: EngageSmart, Inc. (NYSE – ESMT), WaveDancer, Inc. (Nasdaq – WAVD), Graphite Bio, Inc. (Nasdaq – GRPH), CapStar Financial Holdings, Inc. (Nasdaq – CSTR),

GRAPHITE BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Graphite Bio, Inc. - GRPH

Gene editing stocks mixed despite world’s first CRISPR drug

Gene editing stocks were mixed even after CRISPR Therapeutics (CRSP) and Vertex Pharma (VRTX), in a world's first, won U.K. nod for a CRISPR-based drug. Read more here.

Shareholder Alert: Ademi LLP investigates whether Graphite Bio, Inc. has obtained a Fair Price in its transaction with LENZ Therapeutics

/PRNewswire/ -- Ademi LLP is investigating Graphite Bio (NASDAQ: GRPH) for possible breaches of fiduciary duty and other violations of law in its transaction...

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: WaveDancer, Inc. (Nasdaq – WAVD), Selecta Biosciences, Inc. (Nasdaq – SELB), Graphite Bio, Inc. (Nasdaq – GRPH), CapStar Financial Holdings, Inc. (Nasdaq – CSTR)

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NWLI, GRPH, BVH, GAN

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

GRPH Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Graphite Bio, Inc. Is Fair to Shareholders

LENZ Therapeutics and Graphite Bio Announce Merger Agreement

Graphite Bio CFO resigns to pursue other opportunities (NASDAQ:GRPH)

Graphite Bio (GRPH) CFO Alethia Young to step down to pursue other opportunities.Ms

Graphite Bio Announces Departure of Chief Financial Officer

Graphite Bio Reports Recent Business Progress and Fourth Quarter and Fiscal Year 2022 Financial Results

GRPH stock gains even as downgrades pile up (NASDAQ:GRPH)

Graphite Bio (GRPH) gained Thursday, even as Wall Street analysts downgraded it following its decision to halt research into a sickle cell disease candidate. Read the full story here.

Graphite Bio stock up 19% despite 50% workforce reduction (NASDAQ:GRPH)

Graphite Bio (GRPH) would reduce the company’s workforce by ~50% as a part of corporate restructuring and will reduce cash burn.The company has decided to discontinue further development...

Graphite Bio Announces Process to Explore Strategic Alternatives and Corporate Restructuring

Graphite Bio in the red after downgrade by BofA Securities (NASDAQ:GRPH)

Graphite Bio (GRPH) was down around -9% on Wednesday after BofA Securities downgraded the stock to Neutral from Buy, with a price target of $3 (down from $7).BofA Securities analysts...